Meticulous Research– a leading global market research company published a research report titled “Research Antibodies and Reagents Market by Product {Antibodies [Type (Primary, Secondary), Production, Source, Research Area (Oncology, Neurology)], Reagents}, Technology (ELISA, Western Blot), Application, End User (Pharma, Academia) - Global Forecast to 2027”.

According to this latest publication fsssrom Meticulous Research, the research antibodies and reagents market is expected to grow at a CAGR of 5.6% from 2020 to reach USD 6.32 billion by 2027. Increasing proteomics & genomics research studies, increasing funding for research activities, and growing industry-academia collaborations are majorly driving the research antibodies and reagents market. Also, rising stem cell research, emerging economies, rising biomarker discovery, and increasing protein-based research are stimulating this market's growth. However, factors such as high cost and time related to identifying & developing potential antibodies hinder the market's growth.

Research Antibodies and Reagents Market: Future Outlook
The research antibodies and reagents market study presents historical market data in terms of values (2018 and 2019), estimated current data (2020), and forecasts for 2027. The research antibodies and reagents market study includes the market analysis by Product {Antibodies [Type (Primary Antibody, Secondary Antibody), Production Type (Monoclonal Antibody, Polyclonal Antibody, and Antibody Fragments), Source (Mouse, Rabbit, and others), Research Area (Oncology, Cardiovascular Disease, Infectious Diseases, Immunology, Neurology, Stem Cell Research, and Others)], Reagents [Sample Preparation Reagents (Media and Serum, Stain and Dyes, Probes, Buffers, and Solvents), Antibody Production Reagents (Enzymes and Proteins), Other Research Reagents}, Technology (Western Blot, Immunofluorescence, ELISA, Multiplex Immunosorbent Assay, Flow Cytometry, Immunohistochemistry, Immunoprecipitation, and Others), Application (Proteomics, Drug Discovery and Development, and Genomics), End User (Pharmaceutical and Biotechnology Industry, Academic and Research Institutes, and Contract Research Organizations), and Geography. The study also evaluates industry competitors and the market at the regional and country levels.

Based on product, the reagents segment is projected to grow at the fastest rate of the overall research antibodies and reagents market. This can be attributed to the growing demand for various reagents in many routine assays and techniques, increasing focus on understanding the molecular basis of diseases, routine use in target-based assays during basic research, rising focus on product innovation, and increasing demand for technologically advanced reagents.

In 2020, the flow cytometry segment is poised to command the largest share of the research antibodies and reagents market. Raising demand for antibody & cell-based research and rising biomarker discovery are the factors driving the growth of this segment.

In 2020, the proteomics segment is poised to command the largest share of the research antibodies and reagents market. Growing focus on proteomics research, increasing uptake of antibodies for proteomics, and rising need for designing more effective drugs through protein-based disease profiling are the factors driving the growth of this segment.

In 2020, the pharmaceutical and biotechnology industry segment is poised to command the largest share of the research antibodies and reagents market. The larger adoption of antibodies for proteomics research and drug discovery & development by this end-user is driving the growth of this segment.

This research report analyzes major geographies and provides a comprehensive analysis for North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, and Rest of Asia Pacific), Latin America, and the Middle East & Africa.

In 2020, Asia-Pacific is projected to dominate the research antibodies and reagents market, followed by Europe and North America. Emerging economies, low regulatory hindrance, improving healthcare infrastructure, rising middle-income people, rising accessibility to healthcare services & products, and continuous R&D development in the pharma & biotech sector are the factors driving the APAC market.

The key players operating in the research antibodies and reagents market are GE Healthcare (U.S.), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann La-Roche AG (Switzerland), Rockland Immunochemicals Inc. (U.S.), Johnson & Johnson (U.S.), Agilent Technologies, Inc. (U.S.), Eli Lily and Company (U.S.), Becton Dickinson and Company (U.S.), Danaher Corporation (U.S.), PerkinElmer, Inc. (U.S.), GenScript Biotech Corporation (U.S.), Lonza (Switzerland), Bio-Techne Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Teva Pharmaceutical Industries Limited (Israel), Santa Cruz Biotechnology, Inc. (U.S.), and BioLegend, Inc. (U.S.).

Key questions answered in the report-
· Which are the high growth market segments in terms of product, technology, application, end-user, and region/countries?
· What was the historicsal market for research antibodies and reagents across the globe?
· What are the market forecasts and estimates for the period 2020-2027?
· What are the major drivers, restraints, opportunities, and trends in the research antibodies and reagents market?
· Who are the major players in the research antibodies and reagents market?
· How is the competitive landscape, and who are the market leaders in the research antibodies and reagents market?
· What are the recent developments in the research antibodies and reagents market?
· What are the different strategies adopted by the major players in the research antibodies and reagents market?
· What are the geographical trends and high growth regions/countries?

Get Sample Report with all Graphs & Charts related to it @ https://www.meticulousresearch.com/download-sample-report/cp_id=5055

Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research